Half of 4.3 million undocumented TB cases in India, Indonesia,

Image
Press Trust of India New Delhi
Last Updated : Mar 08 2017 | 7:57 PM IST
India, Indonesia and Nigeria accounted for almost half of the estimated 4.3 million cases of tuberculosis worldwide that were not documented by the health authorities in 2015, the World Health Organization (WHO) has said.
Noting that there were estimated 10.4 million new TB cases worldwide in 2015, the global health body said that six countries including India accounted for 60 per cent of these.
Of these new cases, 5.9 million were men, 3.5 million were women and 1 million were children.
People living with HIV accounted for 11 per cent of the total figure, the WHO said.
"Six countries accounted for 60 per cent of the new cases -- India, Indonesia, China, Nigeria, Pakistan and South Africa," it added.
"In 2015, 6.1 million new TB cases were notified to national authorities and reported to the WHO. This reflects a 4.3 million gap between incident and notified cases, with India, Indonesia and Nigeria accounting for almost half of this gap," the global body said.
2017 is the second year of the two-year "Unite to End TB" campaign for World TB Day and this year the WHO will place a special focus on uniting efforts to "Leave No One Behind", including actions to address stigma, discrimination, marginalisation and overcome barriers to access care.
It is also an opportunity to mobilise political and social commitment for further progress in efforts to end TB, it said.
The WHO said that about 4,80,000 people worldwide developed multidrug-resistant tuberculosis (MDR-TB) in 2015.
In addition, around 1,00,000 people developed resistance to rifampicin (the most effective first-line medicine) and needed MDR-TB treatment.
"The MDR-TB burden largely falls on three countries -- China, India, and the Russian Federation -- which together account for nearly half of the global cases," the WHO said.
MDR-TB is a form of TB caused by bacteria that do not respond to isoniazid and rifampicin, the two most powerful, first-line anti-TB drugs.
TB is one of the top 10 causes of death worldwide. In 2015, 10.4 million people suffered from TB and 1.8 million died from the disease, including 0.4 million of those with HIV.
"Over 95 per cent of TB deaths occur in low- and middle-income countries," it said.
"49 million lives were saved through effective diagnosis and treatment in 2000-2015, 4,80,000 people developed multidrug-resistant TB in the world in 2015 and two billion US dollars per year needed to fill the resource gap for implementing existing TB interventions," the WHO said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 08 2017 | 7:57 PM IST

Next Story